dcsimg Application Proof
 
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
YOU SHOULD READ THE WARNING IN THE DOCUMENT.
 
► Warning
► Important
► Expected Timetable
► Contents
► Summary
► Definitions
► Glossary of Technical Terms
► Forward-looking Statements
► Risk Factors
► Waivers and Consents from Strict Compliance with the Hong Kong Listing Rules
► Information about this Document and the [REDACTED]
► Directors, Supervisors and Parties Involved in the [REDACTED]
► Corporate Information
► Industry Overview
► Regulatory Environment
► History, Development and Corporate Structure
► Business
► Relationship with the Controlling Shareholders
► Connected Transaction
► Directors, Supervisors and Senior Management
► Share Capital
► Substantial Shareholders
► Financial Information
► Future Plans and Use of [REDACTED]
► [REDACTED]
► Structure of the [REDACTED]
► How to Apply for the [REDACTED]
► Appendix I - Accountants' Report
► Appendix II - [REDACTED]
► Appendix III - Taxation and Foreign Exchange
► Appendix IV - Summary of Principal Legal and Regulatory Provisions
► Appendix V - Summary of Articles of Association
► Appendix VI - Statutory and General Information
► Appendix VII - Documents Delivered to the Registrar of Companies in Hong Kong and Available for Inspection